Abstract

Liver steatosis is a common complication of chronic hepatitis C virus (HCV) infection, which can result in accelerated liver fibrosis development, especially in patients infected with genotype 3a. The precise mechanisms of HCV-induced liver steatosis remain unclear, but it is often posited that increased intracellular lipid accumulation is the underlying cause of steatosis. To study experimentally how HCV infection in human liver derived cells by different genotypes and subtypes might affect lipid accumulation, we performed detailed cytofluorimetric and microscopy analyses of intracellular lipid droplets (LDs) in relation to the viral Core and to cell endoplasmic reticulum proteins. Following culture infection with HCV genotype 1a, 2a, 2b, 2c, and 3a strains, we found variable levels of intracellular LDs accumulation, associated to the infecting strain rather than to the specific genotype. Although two genotype 3a strains showed high levels of lipid accumulation, as previously observed, some strains of other genotypes displayed a similar phenotype. Moreover, the analyses of LDs size, number, and shape indicated that the apparent increase in lipid accumulation is due to an increase in the overall number rather than in the size of droplets. Finally, differences in total lipid content across genotypes did not correlate to differences in Core distribution nor Core levels. In conclusion, our study provides a quantitative in-depth analysis of the effect of HCV infection on LDs accumulation in cell-culture.

Highlights

  • Published: 28 February 2021Persistent infection with hepatitis C virus (HCV) is a leading cause of liver fibrosis, cirrhosis, and cancer

  • We investigated the increase in cellular lipid droplets (LDs) content produced by different HCV strains during the early stages of infection

  • Steatosis of the liver has long been recognized as a hallmark of HCV infection, especially in genotype 3a infections

Read more

Summary

Introduction

Persistent infection with hepatitis C virus (HCV) is a leading cause of liver fibrosis, cirrhosis, and cancer. At least 400,000 people die from HCV-related diseases worldwide [1]. Due to the high viral genetic variability, HCV has been classified into eight major genotypes, six of which are considered of epidemiological relevance, and at least. 90 subtypes [2,3,4,5]. Strains belonging to different genotypes and subtypes differ by about. HCV genotypes 1, 2, and 3 account for more than 80% of global infections. Genotypes and subtypes have been linked to differences in pathogenicity, as well as in treatment response, including the propensity to developing antiviral resistance [6,7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call